While the data suggest differences in immune cell-derived protease activity and the resulting elastin degradation, the separation between IBD patients and healthy donors does not indicate a diagnostic use of ELP-3 and ELM-12. The gene discussed is ELN; the disease is inflammatory bowel disease.